Prof. Dr. Peter Brossart
Medical Clinic III for Haematology and Oncology
peter.brossart@ukbonn.de View member: Prof. Dr. Peter Brossart
Cell reports
Anti-neutrophil cytoplasmic antibodies (ANCAs) target antigens in neutrophil granules, such as myeloperoxidase (MPO) or proteinase 3, causing small-vessel inflammation. ANCA pathogenicity is typically attributed to direct neutrophil activation, but a comprehensive understanding of its mode of action is lacking. In this study, we elucidate an alternative mechanism underlying anti-MPO IgG (αMPO)-dependent immune activation. We demonstrate that MPO binds to extracellular DNA and protects it from nuclease degradation. Antibodies against MPO promote its FcγR-mediated uptake into murine GM-CSF-derived bone marrow myeloid cells (GM-BMCs). Importantly, complexing DNA with MPO and αMPO greatly enhances its ability to activate GM-BMCs in a Toll-like receptor 9 (TLR9)-dependent manner. This immunostimulatory effect occurs with both a bacterial plasmid-templated polymerase chain reaction (PCR) product and neutrophil "self" DNA and is validated in human pDCs. Our results reveal how MPO and αMPO cooperate to facilitate TLR9-dependent sensing of extracellular DNA and thus immune activation in ANCA-associated vasculitis.
Copyright © 2026 The Authors. Published by Elsevier Inc. All rights reserved.
PMID: 42789389
Medical Clinic III for Haematology and Oncology
peter.brossart@ukbonn.de View member: Prof. Dr. Peter BrossartMedical Clinic III
valentin.schaefer@ukbonn.de View member: Prof. Dr. Valentin Sebastian SchäferInstitute of Experimental Immunology (IEI)
ngarbi@uni-bonn.de View member: Prof. Dr. Natalio GarbiMedical Clinic III
lino.teichmann@ukbonn.de View member: Dr. Lino Teichmann